Conway Regional Health System
Advanced Search

Health Information

Search Health Information   Print This Page Print    Email to a Friend Email
 

CSF analysis

Definition

Cerebrospinal fluid (CSF) analysis is a group of laboratory tests that measure chemicals in the fluid that surrounds and protects the brain and spinal cord. The tests may look for proteins, sugar (glucose), and other substances.

Alternative Names

Cerebrospinal fluid analysis

How the Test is Performed

A sample of CSF is needed. A lumbar puncture, also called a spinal tap, is the most common way to collect this sample. Less common ways to take a fluid sample include:

After the sample is taken, it is sent to the laboratory for evaluation.

How to Prepare for the Test

Your health care provider will tell you how to prepare for lumbar puncture.

Why the Test is Performed

Analysis of CSF can help detect certain conditions and diseases. All of the following can be, but are not always, measured in a sample of CSF:

Normal Results

Normal results include:

  • Antibodies and DNA of common viruses: None
  • Bacteria: No bacteria grows in a lab culture
  • Cancerous cells: No cancerous cells present
  • Cell count: less than 5 white blood cells (all mononuclear) and 0 red blood cells
  • Chloride: 110 to 125 mEq/L
  • Fungus: None
  • Glucose: 50 to 80 mg/dL(or greater than two-thirds of blood sugar level)
  • Glutamine: 6 to 15 mg/dL
  • Lactate dehydrogenase: less than 2.0 to 7.2 U/mL
  • Oligoclonal bands: 0 or 1 bands that are not present in a matched serum sample
  • Protein: 15 to 60 mg/dL

Normal value ranges may vary slightly among different laboratories. Talk to your doctor about the meaning of your specific test results.

The examples above show the common measurements for results for these tests. Some laboratories use different measurements or may test different specimens.

Note: mg/dL = milligrams per deciliter

What Abnormal Results Mean

An abnormal CSF analysis result may be due to many different causes, including:

References

Griggs RC, Jozefowicz RF, Aminoff MJ. Approach to the patient with neurologic disease. In: Goldman L, Schafer AI, eds. Goldman's Cecil Medicine. 25th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 396.

Martorana A, Sancesario GM, Esposito Z, et al. Plasmin system of Alzheimer's disease: CSF Analysis. J Neural Transm. 2012:119:763-769. PMID: 22415062. www.ncbi.nlm.nih.gov/pubmed/22415062.

Rosenberg GA. Brain edema and disorders of cerebrospinal fluid circulation. In: Daroff RB, Fenichel GM, Jankovic J, Mazziotta JC, eds. Bradley's Neurology in Clinical Practice. 6th ed. Philadelphia, PA: Elsevier Saunders; 2012:chap 59.


Review Date: 6/1/2015
Reviewed By: Daniel Kantor, MD, Kantor Neurology, and Immediate Past President of the Florida Society of Neurology (FSN), Coconut Creek, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com
 
Contact Us: 1-800-245-3314 or (501) 329-3831 2302 College Avenue, Conway, Arkansas 72034
I am...
Condidtions We Treat
Patient Toolbox
Visitor Guide
About Us